(Q44139569)

30 November 2017

Pharmacokinetics of rosiglitazone in patients with end-stage renal disease (English)

1 reference

30 November 2017

1 reference

1 reference

K Thompson-Culkin

1

1 reference

30 November 2017

B Zussman

series ordinal

2

1 reference

30 November 2017

A K Miller

series ordinal

3

1 reference

30 November 2017

M I Freed

series ordinal

4

1 reference

30 November 2017

1 July 2002

1 reference

Journal of International Medical Research

30 November 2017

1 reference

30 November 2017

30

1 reference

30 November 2017

4

1 reference

30 November 2017

391-399

1 reference

NIDDM is the Major Cause of Diabetic End-Stage Renal Disease: More Evidence From a Tri-Ethnic Community

30 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

Model of complications of NIDDM. I. Model construction and assumptions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

End-stage renal disease attributable to diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

Nephropathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

Renal disease and hypertension in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

Factors influencing drug protein binding in patients with end stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

Systemic exposure to rosiglitazone is unaltered by food

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

Nonlinear pharmacokinetics: clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000203000405

10.1177/147323000203000405

21 January 2018

Identifiers

DOI

1 reference

release_ozbn5ioqsjfaheq7oo6qc5lvla

30 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ozbn5ioqsjfaheq7oo6qc5lvla

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference